We then examined the efficacy of combining CXCR4 inhibition with RT in the syngeneic mouse model of bone metastatic PCa, using Pten/Smad4-null cells implanted in the tibia of F1 mixed background (FVB × C57Bl/6) mice. This evidence concerns the gene CXCR4 and posterior cortical atrophy.